

EPO, night willow herb, fever plant, king's cure-all
Derived from the plant Oenothera biennis, evening primrose oil (EPO) is used for rheumatoid arthritis, premenstrual syndrome, eczema, fatigue, diabetic neuropathy and mastalgia. EPO contains gamma-linolenic acid (GLA), a primary fixed oil that is converted to dihomo-gamma-linolenic-acid, a prostaglandin precursor (2) (3).
In vitro studies indicate that EPO may inhibit platelet aggregation (6) (7). Clinical efficacy data are inconsistent. EPO has been shown in small studies to be effective against atopic dermatitis (18) and 5-azacitidine-induced skin reactions in patients with myelodysplastic syndromes (MLD) (19). It may also prevent weight regain in individuals who recently experienced major weight loss (5). Supplementation with vitamin E and EPO may reduce cyclical mastalgia (20). However, conclusions from a meta analysis indicate that EPO is ineffective against mastalgia (1). Further research is needed.
In one study, GLA was reported to be an effective adjunctive therapy for breast cancer (4).
Adverse reactions include headache and GI disturbances. EPO should not be taken during pregnancy (8).
One study reported a reduced seizure threshold when EPO was combined with phenothiazine antipsychotics (9).
Although EPO does not have intrinsic estrogenic properties, some commercial products combine EPO with phytoestrogens. Patients with hormone-sensitive cancer should use EPO products with caution.
Theoretically, GLA can be converted directly to the prostaglandin, precursor dihomo-GLA. The administration of the oil might be beneficial to individuals unable to metabolize cis-linolenic acid to GLA and to produce subsequent intermediates of considerable metabolic significance, including prostaglandins.
(2) (3)
Repeated oral administration of evening primrose oil (480 mg/day gamma-linoleic acid/day) to healthy volunteers resulted in mean Cmax of approximately 20.7-22.6 mcg/ml. Gamma-linoleic acid levels were approximately 4.5 times greater from baseline in all patients, but serum levels of other fatty acids did not change significantly from baseline. Gastric absorption and Tmax for morning doses was longer than Tmax for identical doses given in the evening.
(11)
Pregnant women should not take evening primrose oil due to increased risk of pregnancy complications. (8)
Reported: Headache, GI upset, nausea, and increased risk of pregnancy complications
Petechiae and ecchymoses were observed in a neonate whose mother used raspberry leaf tea and evening primrose oil (vaginally and orally) 1 week before childbirth.
(12)
Anticoagulants / Antiplatelets: May have additive effects and increase risk of bleeding.
Phenothiazines (e.g. fluphenazine): Evening primrose oil may lower the seizure threshold and precipitate seizures in patients taking phenothiazines.
(9)
Blommers J, et al. Evening primrose oil and fish oil for severe chronic astalgia: a randomized, double-blind, controlled trial. Am J Obstet Gynecol. 2002 Nov;187(5):1389-94.
This clinical trial involved one hundred and twenty premenopausal women to evaluate the effect of evening primrose oil and fish oil on mastalgia. The author concluded that primrose oil is no better than a placebo (wheat-germ oil) in treating breast pain.
Srivastava A, et al. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast. Oct 2007;16(5):503-512.
In a meta-analysis of commonly used treatments for mastalgia, including Evening primrose oil (EPO), Bromocriptine, Danazol, and Tamoxifen, previously reported randomized, placebo-controlled trials were analyzed. Three randomized, controlled trials of EPO were included along with 1 trial of gamma-linolenic acid. Although Bromocriptine, Danazol, and Tamoxifen improved mastalgia, EPO was ineffective and therefore should not be used for mastalgia relief.
Bottom Line: Evening primrose oil has not been shown to treat or prevent cancer.
Scientists have not figured out how exactly evening primrose oil exerts its effects, but theorize that it has anti-inflammatory activity. It may be beneficial for patients with mastalgia (breast pain). It may also help those with diabetes, heart disease, cancer, premenstrual syndrome, eczema, or high cholesterol but there is not enough data to support such effects.
Premenstrual syndrome (PMS):
A meta-analysis compiled and analyzed the results of seven clinical trials that used evening primrose oil to prevent premenstrual syndrome. Overall, evening primrose oil had no consistent effect on premenstrual syndrome. However, most of the clinical trials were small, so it may be the case that no effect was seen simply because there were too few patients. Nonetheless, on current evidence, evening primrose oil is of little value in the management of premenstrual syndrome.
Mastalgia (breast pain):
The results of several clinical trials and volunteer studies conducted in the United Kingdom were compiled to measure the effect of evening primrose oil on mastalgia (breast pain). Overall, evening primrose oil was found to have a similar level of effectiveness as bromocriptine (a drug used to treat mastalgia), having beneficial effects in 44% of women treated. However, this was less effective than treatment with danazol, another medication. Treatment with evening primrose oil was more effective in women with cyclical mastalgia than in women with non-cyclical pain. Another study found evening primrose oil no more effective than wheat-germ oil in the treatment of breast pain.